MedTrace Logo

Aflatoxin Birth Cohort Study Nepal (AflaCohort)

NCT03312049 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1675

Last updated 2019-05-10

No results posted yet for this study

Summary

The study focuses on the causal relationship between mycotoxin exposure (particularly aflatoxin B1), birth outcomes, and height for age among young children in Nepal. Previous studies have shown a strong association of stunting with mycotoxin exposure yet causality has not been proven. Thus, this study will provide a better understanding of the association between maternal and/or early life mycotoxin exposure (rates in the blood and breast milk) and infant and young child growth. This information is essential if we are to more fully understand and effectively address the high rates of stunting in Asia.

Conditions

  • Stunting
  • Birth Weight
  • Birth Length
  • Height for Age
  • Linear Growth Failure

Sponsors & Collaborators

  • Helen Keller International

    collaborator OTHER

  • Patan Academy of Health Sciences

    collaborator OTHER

  • Purdue University

    collaborator OTHER

  • Government of Nepal

    collaborator UNKNOWN

  • Nepalgunj Medical College

    collaborator UNKNOWN

  • Tufts University

    lead OTHER

Principal Investigators

  • Patrick Webb, PhD · Tufts University

  • Kedar P Baral, MD · Patan Academy of Health Sciences

  • Shibani Ghosh, PhD · Tufts University

Eligibility

Min Age
16 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-06
Primary Completion
2019-03-31
Completion
2019-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03312049 on ClinicalTrials.gov